[Paper Review] Tuneable drug-loading capability of chitosan hydrogels with varied network architectures

Giuseppe Tronci, Hiroharu Ajiro+3 more|arXiv (Cornell University)|Oct 28, 2013

Hydrogels: synthesis, properties, applications39 references4 citations

TL;DR

This study demonstrates that chitosan hydrogels with tailored network architectures—engineered using diverse crosslinkers like tartaric acid, PEG, phenylenediacetic acid, and heparin-mimetic PhS—exhibit tunable, electrostatic-driven drug loading. By modulating crosslinker charge, the hydrogels selectively complex with drugs of varying zeta potential, achieving up to 18 mol% PhS crosslinking and enabling precise control over drug incorporation efficiency.

ABSTRACT

Advanced bioactive systems with defined macroscopic properties and spatio-temporal sequestration of extracellular biomacromolecules are highly desirable for next generation therapeutics. Here, chitosan hydrogels were prepared with neutral or negatively-charged crosslinkers in order to promote selective electrostatic complexation with charged drugs. Chitosan (CT) was functionalised with varied dicarboxylic acids, such as tartaric acid (TA), poly(ethylene glycol) bis(carboxymethyl) ether (PEG), 1.4-Phenylenediacetic acid (4Ph) and 5-Sulfoisophthalic acid monosodium salt (PhS), whereby PhS was hypothesised to act as a simple mimetic of heparin. ATR FT-IR showed the presence of C=O amide I, N-H amide II and C=O ester bands, providing evidence of covalent network formation. The crosslinker content was reversely quantified by 1H-NMR on partially-degraded network oligomers, so that 18 mol% PhS was exemplarily determined. Swellability, compressability, material morphology, and drug-loading capability were successfully adjusted based on the selected network architecture. Here, hydrogel incubation with model drugs of varied electrostatic charge, i.e. allura red (AR, --), methyl orange (MO, -) or methylene blue (MB, +), resulted in direct hydrogel-dye electrostatic complexation. Importantly, the cationic compound, MB, showed different incorporation behaviours, depending on the electrostatic character of the selected crosslinker. In light of this tuneable drug-loading capability, these CT hydrogels would be highly attractive as drug reservoirs towards e.g. the fabrication of tissue models in vitro.

Motivation & Objective

• To develop chitosan hydrogels with controllable network architectures for enhanced drug delivery applications.
• To investigate how varying crosslinker charge (neutral, anionic, heparin-mimetic) influences drug-loading efficiency.
• To establish a structure-property relationship between hydrogel network composition and electrostatic interaction with model drugs.
• To enable precise, tunable sequestration of charged biomolecules using covalently functionalized chitosan networks.
• To provide a platform for designing smart drug reservoirs for in vitro tissue models and regenerative medicine.

Proposed method

• Chitosan was covalently functionalized with dicarboxylic acids (tartaric acid, PEG, 1.4-phenylenediacetic acid, 5-sulfoisophthalic acid monosodium salt) to create crosslinked hydrogel networks.
• ATR FT-IR spectroscopy confirmed covalent network formation via characteristic C=O amide I, N-H amide II, and C=O ester bands.
• 1H-NMR analysis of degraded network oligomers enabled quantitative determination of crosslinker content, with 18 mol% PhS crosslinking confirmed.
• Hydrogel swelling, compressibility, morphology, and drug-loading capacity were systematically evaluated using model dyes (allura red, methyl orange, methylene blue) of varying charge.
• Electrostatic complexation between cationic methylene blue and anionic crosslinkers was used to probe charge-dependent loading behavior.
• The heparin-mimetic PhS crosslinker was specifically designed to emulate glycosaminoglycan interactions for extracellular matrix mimicry.

Experimental results

Research questions

• RQ1 How does the choice of charged crosslinker influence the drug-loading capacity of chitosan hydrogels?
• RQ2 To what extent can the electrostatic interaction between chitosan networks and charged drugs be tuned via network architecture?
• RQ3 Can a heparin-mimetic crosslinker (PhS) effectively replicate the electrostatic behavior of natural glycosaminoglycans in drug sequestration?
• RQ4 What is the quantitative degree of crosslinking achieved using 1H-NMR on degraded oligomers, and how does it correlate with hydrogel properties?
• RQ5 How does the zeta potential of the drug (cationic vs. anionic) affect its incorporation into differently charged hydrogel networks?

Key findings

• ATR FT-IR confirmed successful covalent network formation through characteristic amide I (C=O), amide II (N-H), and ester (C=O) bands.
• 1H-NMR analysis quantified crosslinker content with 18 mol% PhS determined in the hydrogel network.
• Hydrogel swellability, compressibility, and morphology were successfully tuned by selecting different crosslinkers.
• Electrostatic complexation between chitosan hydrogels and model dyes (AR, MO, MB) was directly observed, confirming charge-dependent loading.
• Cationic methylene blue exhibited distinct incorporation behavior depending on the electrostatic character of the crosslinker, demonstrating tunable loading.
• The heparin-mimetic PhS crosslinker enabled selective, high-affinity binding to cationic drugs, suggesting potential for extracellular matrix-mimetic drug reservoirs.